Objective: Venoarterial extracorporeal membrane oxygenation (ECMO) is a salvage therapy in patients with severe cardiopulmonary failure. Owing to the large size of the cannulas inserted via the femoral vessels (#24-F) required for adequate oxygenation, this procedure could result in significant limb ischemic complications (10%-70%). This study evaluates the results of a distal limb perfusion arterial protocol designed to reduce associated complications.
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a salvage therapy for patients with refractory cardiopulmonary failure. Peripheral femoral cannulation is quick and a commonly used technique for bedside placement of VA-ECMO. 1 To achieve adequate oxygenation and flow, large cannulas (#24-F) are necessary. The combination of hemodynamic instability and obstruction of arterial flow by the indwelling arterial cannula results in limb ischemia in 10% to 70% [2] [3] [4] [5] [6] of cases, with a relative paucity of data on the rates of amputation. 1, 7 Strategies to reduce the risk of limb ischemia after ECMO cannulation have included placement of an antegrade distal perfusion catheters (DPCs) into the proximal superficial femoral artery (SFA), 2, 3, 5, 6 and use of limb nearinfrared spectroscopy (NIRS). 4, [8] [9] [10] Investigators have advocated particularly for the use of DPC after review of their own institutional data, suggesting that this technique may prevent devastating limb complications. However, to date, none of these investigators have proposed a comprehensive model to use DPC and other modalities prophylactically to reduce this devastating complication. This study evaluates a protocol designed to address the problem of limb ischemia in patients placed on ECMO. The protocol involves percutaneous placement of a DPC antegrade into the proximal SFA at the time of ECMO cannula insertion, continuous monitoring with NIRS, and open repair of the femoral circulation at the time of decannulation. We retrospectively review our experience with a series of patients supported with peripherally cannulated VA-ECMO in our institution.
METHODS
Patients. The Institutional Review Board of Thomas Jefferson University approved a record review of all adult patients (age > 18 years) managed on ECMO at Thomas Jefferson University Hospital from July 2010 to January 2015. Informed consent was not obtained because this study posed minimal risk to patients. Patients who underwent peripheral VA cannulation were included in this study; patients who underwent central cannulation, peripheral cannulation with cut down, or venovenous ECMO were excluded from this study. Basic demographic data and indications for and duration of ECMO were retrieved. Index hospitalization records were reviewed to obtain details of clinical course after ECMO.
ECMO cannulation. Percutaneous femoral VA-ECMO cannulation has been described previously in detail by our group. 1 Briefly, the femoral vessels (either unilateral or one side arterial, one side venous) were accessed retrograde using an angiogram needle. Flexible j-tip guidewires (Edwards Life Sciences Corporation, Irvine, Calif) (0.038 in Â 210 cm) were advanced centrally. A heparin bolus of 5000 units IV intravenously was administered. The artery and vein were serial dilated followed by placement of the arterial and venous ECMO cannulas. The venous cannula was either 55 or 68 cm in length and 18-F to 28-F (Edwards Life Sciences Corporation); the arterial cannula was 24 cm and 16-F to 24-F (OptiSite Arterial Cannula, Edwards Life Sciences Corporation). The final cannula selection was based on reference of the manufacturer pressure-flow curves for each cannula size 6 and patient size. The cannulas were attached to the ECMO circuit that included a Quadrox-D oxygenator and a Rotaflow centrifugal pump (MAQUET Cardiovascular, LLC, Wayne, NJ).
Distal perfusion catheterization. The proximal SFA ipsilateral to the arterial cannula was accessed antegrade using a micropuncture needle followed by a 0.018-inch nitinol wire (Cook Medical Inc, Bloomington, Ind). The 5-F DPC (Cook Medical Inc) was advanced into the mid-SFA. The catheter was attached to the side port of the arterial cannula using 6-inch extension tubing with an intervening three-way stopcock.
Postcannulation management. Anticoagulation with heparin IV was begun 24 hours after cannula placement, with a goal A prothrombin time of 40 to 45 seconds (normal, 26-38). After 48 hours, the prothrombin time was maintained at 45 to 55 seconds. Anticoagulation was initiated earlier if thrombi were detected within the circuit or oxygenator, or in the event of desaturation. Continuous monitoring of limb perfusion was begun immediately after commencement of ECMO and measured using bilateral NIRS as previously described. 9 The baseline NIRS saturation of peripheral oxygen of greater than 40 to 50 has, in the literature for neurocognitive status after cardiac bypass, suggested good perfusion and has been extrapolated for use in limb oximetry. 10, 11 A diagnosis of acute limb ischemia ipsilateral to the arterial cannula was defined as (1) physical examination indicating ischemia (sudden onset of pain, pallor, or mottling), demarcation, loss of Doppler signal in the extremity, motor paralysis, or sensory deficit, (2) loss of Doppler signal in the foot, or (3) decrease in NIRS from baseline or below a saturation of peripheral oxygen of 40.
In the event of limb ischemia, emergent vascular surgical consultation was obtained with subsequent management based on the clinical condition of the patient as well as the limb. In the absence of a DPC, this was placed percutaneously at the bedside.
Decannulation technique. ECMO decannulation was performed in the operating room. Before making the incision, continuous heparin drip was continued. Femoral cut down was performed, gaining proximal and distal control of the femoral artery and vein around the cannula insertion sites. The cannulas were removed. The femoral venotomy was closed primarily. The arteriotomy was closed primarily, in a transverse direction. If the femoral vessel required debridement owing to prolonged cannulization or had significant athermanous burden, patch angioplasty was performed using a bovine pericardial patch (XenoSure Biologic Vascular Patch; LeMaitre Vascular, Richmond, BC, Canada). Dissection further along the SFA exposed the entry point of the DPC, which was removed and repaired primarily. If the intervening segment of the common and SFA were occluded, patency was restored via catheter thrombectomy vs thrombus endarterectomy before patch closure.
Statistical analysis. Statistical analysis was performed using unpaired the t-test for continuous variables and c 2 or Fisher's exact tests for categorical variables. Binary multivariable logistic regression was used to evaluate for confounding in subgroups with greater than 10 events. All statistical analysis was run in SPSS 23.0 (IBM, Chicago, Ill).
RESULTS
Demographics. Ninety-one patients were supported with percutaneous femoral VA-ECMO. Indications for ECMO included cardiogenic shock in 73, acute respiratory failure with our without acute respiratory distress syndrome in 14, cardiorespiratory failure related to pulmonary embolism in 3, and left ventricular assist device failure in 1. The details of the patient's demographics are listed on Table I .
Development of ischemia.
At the time of femoral cannulation, DPC was placed in 55 of 91 patients (60%) and none developed subsequent limb ischemia. Of the remaining 36 patients (40%) without a DPC catheter, 12 (33%) developed acute limb ischemia (Fig 1) . For those who developed acute limb ischemia, various interventions were performed including DPC placement in two patients, DPC placement and fasciotomy in five, and fasciotomy only in four. Additionally, one patient required amputation upon presentation to our hospital because he was cannulated at an outside facility. All seven patients with emergent DPC placement after acute ischemia had resolution of symptoms after DCP placement, NIRS tracings that returned to preischemic values, and these limbs survived. The remaining 17 patients without DPC placement experienced no signs of vascular compromise. Reasons for not placing DPC included attempted placement leading to failure related to vessel vasoconstriction or vasospasm, small-caliber cannulas, need to return to the intensive care unit for further patient stabilization, or the cannulation took place at an outside institution. We did not encounter any cases of SFA occlusion precluding DPC placement. If this situation was known, either clinically or from ultrasound duplex examination upon cannulation, we would search for an alternate site, such as the other limb or centrally. If no other site was available, we would monitor the limb without DPC and manage the situation expectantly. No difference in ischemia was noted when cannulas were placed in ipsilateral or bilateral groins.
Decannulation. At the time of VA-ECMO decannulation, all surviving patients (42%) returned to the operating room for decannulation. Vessel debridement and either open repair or patch angioplasty of the common femoral artery were performed if it was felt that primary closure would lead to arterial stenosis. Ten patients (11%) required patch angioplasty at the time of arterial decanulation. The common femoral vein and SFA we also repaired. An SFA pseudoaneurysm was found in one patient and repaired at the time of decannulation; however, no one had pseudoaneurysm development after cannula removal. There were no acute ischemic events or amputations required after decannulation. Groin wounds were irrigated copiously at the end of the procedure and vessel converge was achieved with autologous tissue, often with the assistance of a dressing with a vacuum assist device, if appropriate.
Infection. Of the 91 patients, 14 (15%) required interventions for groin access complications, primarily related to seroma or hematoma formation. Twelve patients required groin washout and vacuum assist device (VAC, KCI, San Antonio, Tex) negative pressure wound dressing placement. Two patients required washout with muscle flap coverage.
Risk factors for developing ischemia. The 91 patients cannulated on VA-ECMO during the study period were divided into two groups, those with and without limb ischemia (79 patients without limb ischemia vs 12 patients with ischemic limb). On univariate analysis, only the lack of a distal perfusion cannula (100% vs 30%) and ECMO cannulas of greater than 20-F (75% vs 35%) were associated with ischemia. Neither the presence of hypertension, hyperlipidemia, diabetes, obesity, nor postoperative renal failure were not found to be significantly associated with development of limb ischemia (Table II) . Owing to the low rate of overall ischemic events, a multivariable subgroup analysis was unable to be performed.
Risk factors for mortality. Overall survival to hospital discharge was 42% (38 of 91 patients). In the limb ischemia population, overall survival was noted to be inferior, but this was not found to reach significance (25% vs 44% in the nonischemic group; P ¼ .206). Need for dialysis (24% vs 48%; P ¼ .035) and ipsilateral cannulation (26% vs 52%; P ¼ .014) were both significantly associated with lower survival. These maintained significance on multivariable logistic regression when controlling for comorbidities. A detailed comparison of these two groups is provided in Table II .
DISCUSSION
Femoral cannulation for VA-ECMO for patients with severe cardiovascular or pulmonary compromise, particularly a percutaneous approach, enables rapid placement at the bedside or in the operating room. Inherently, limb complications are a morbidity associated with this procedure owing to partial luminal obstruction of the common femoral artery and vein.
The results of this study suggest that a protocol approach involving placement of a DPC at the time of cannulation, physical examination, use of NIRS monitoring, open repair with or without patch angioplasty of the artery, and a trained intensive care staff may decrease the incidence of ischemic complications.
Limb ischemia associated with femoral ECMO has a reported incidence of 10% to 70% [2] [3] [4] [5] [6] for both open and percutaneous cannulation; however, given that the Extracorporeal Life Support Organization registry does not follow limb ischemia rates specifically, the true incidence is somewhat unknown. 12 Increased risk for ischemic complications in the ECMO population has been associated with peripheral vascular disease 1 and younger patient age, presumably owing to a paucity of collateral circulation. It is also hypothesized that the common femoral artery increases in size with age, suggesting that younger patients have less distal flow around the cannula, making them susceptible to ischemia. 6 In our experience, there was an overall trend toward a younger age of patients with ischemia (average age, 44 vs 51; P ¼ .27). Our univariate analysis did not find hypertension, diabetes, hyperlipidemia, peripheral vascular disease, obesity, or postoperative renal failure to be significant for the development of ischemia. The lack of a distal perfusion cannula placement and smaller ECMO cannula size (<20-F) were significant for the development of ischemia. This may suggest that perhaps those susceptible to ischemia are overall younger, healthier patients with less vascular collateralization at the time of cannulation. Additional risk factors for ischemia may be related to difficult bedside decannulation, as described by Zimpfer et al. 3 This finding prompted modification of their procedure to include patch angioplasty if decannulation is difficult technically. In our population, 12 of 91 patients (13.2%) experienced ischemia. None of these 12 patients had a DPC placed at the time of cannulation and limb ischemia ensued. All patients who subsequently had a DPC placed had resolution of their ischemia. One patient required amputation after cannulation at an outside hospital and having frank limb ischemia upon arrival to our institution. Of note, no ischemia occurred in patients with a DPC placed at the time of cannulation, suggesting that cannula size can lead to luminal obstruction and compromise distal limb perfusion without having a DPC placed to ensure distal flow. An association of ischemia in patients without DPCs has been demonstrated in the ECMO literature. Muehrcke et al 13 reported 70% ischemia in their population of 24 ECMO patients without DPC placement at the time of cannulation. Their cannulation protocol was modified to include DCP placement with noted improvement in limb salvage. Foley et al 6 reported 21% ischemia in their 58 patients, all in those without DPCs, although they found no difference in limb ischemia or mortality from prophylactic vs expectant placement of a DPC. These findings strongly suggest that distal arterial perfusion catheters are efficacious to prevent ischemia, and we would advocate that they are most beneficial when placed immediately. Also, placement of DPC can be performed quickly at the bedside using percutaneous techniques and ultrasound guidance with an associated low rate of complications (<1%). 14, 15 Huang et al 4 have advocated placement of a DPC in patients with a mean distal pressure of less than 50 mm Hg, because this is the threshold below which critical limb ischemia develops. From our experience, however, immediate placement of a DPC at the time of cannulation is advantageous because pulsatile flow is still present. Furthermore, early placement will almost ensure sufficient distal perfusion. It is our practice to preferentially place DPCs in all patients unless limited by technical considerations, mainly an inability to cannulate the SFA. In these circumstances, patients are monitored aggressively for signs of early ischemia. In these circumstances, cutdown and exposure of the SFA can be performed; however, this procedure needs to weighed against risk of bleeding complications related to heparinization while on ECMO. An adjunct for monitoring of lower extremity perfusion is use of NIRS. In addition to physical examination, trending the NIRS oximetry tracings may aid in earlier detection of impending ischemia. NIRS tracings below 40 or a 25% or more decrease from baseline prompted evaluation in our NIRS protocol. 9, 16 A decrease in ipsilateral NIRS tracings led to evaluation of the lower extremity with Doppler examination, including replacement of tracing pads if signals are present. In the absence of Doppler signals in the limb, the DPC would be placed (or replaced). In all of our patients, placement of the DPC, if one was not present, led to the resolution of ischemic symptoms. A decrease in bilateral NIRS follows the same protocol, although this was often associated with a decrease in the overall ECMO flow, a thrombus in the oxygenator, or a decrease in hemoglobin, rather than ischemia 9 (Fig 2) .
As described, all of our patients were decannulated with open femoral cutdowns and either primary repair or patch angioplasty of the femoral artery. We recommend open repair at decannulation, because unexpected bleeding, hematoma, pseudoaneurysm, or arteriovenous fistula may occur. This approach also allows SFA thrombectomy and bovine pericardial patch angioplasty if it seems that primary repair will lead to an area of stenosis. No patients developed complications from the open repair perioperatively. Furthermore, no patients cannulated at our institution developed ischemia or required amputation (one patient was transferred to our institution with acute limb ischemia and required immediate amputation upon arrival). Similarly, an investigation by Zimpfer et al 3 was able to identify a statistically significant association between late vascular complications and technical problems at the time of explant and also a history of peripheral vascular disease. This group adapted their decannulation procedure to include patch angioplasty to prevent limb complications after ECMO explantation. Limitations of this study include its retrospective nature and poor patient follow-up. Given the overall increased mortality in the ECMO population and a variety of social situations postdischarge, outpatient follow-up in this population is very limited. Going forward, we hope to evaluate the use of prophylactic DPC prospectively, particularly in high-risk patients.
CONCLUSIONS
ECMO is a life-sustaining procedure in patients with severe respiratory or cardiac decompensation. Percutaneous femoral cannulation allows rapid bedside cannulation, yet can lead to vascular complications of the cannulated limbs. A heightened awareness for potential complications as well as a protocoled approach for intensive monitoring of limb perfusion using physical examination, a trained intensive care staff, continuous NIRS monitoring of limb perfusion, placement of a DPC at the time of cannulation, and open vessel repair at decannulation seems to limit these complications.
